Stock Events

Stock Events

Biofrontera 

$0.92
42
+$0.11+13.83% Wednesday 20:00

Statistics

Day High
0.98
Day Low
0.8
52W High
1.19
52W Low
0.54
Volume
473,976
Avg. Volume
475,068
Mkt Cap
10.73M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

8MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.98
-0.49
-0.01
0.48
Expected EPS
-0.115
Actual EPS
N/A

Financials

-47.58%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
74.64MRevenue
-35.52MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BFRI. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Davis Select U.S. Equity
DUSA
Mkt Cap0
DUSA Pharmaceuticals, Inc. is a direct competitor in the dermatology space, specifically in photodynamic therapy products, similar to Biofrontera's Ameluz for treating actinic keratosis.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. has a diversified portfolio that includes treatments for various conditions, including skin-related diseases, potentially competing with Biofrontera's dermatological products.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. is a global pharmaceutical company with a broad product line that includes treatments for skin conditions, making it a competitor to Biofrontera.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson offers a wide range of healthcare products, including pharmaceuticals and personal care products for skin health, competing with Biofrontera's dermatological treatments.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie Inc., having acquired Allergan, has strengthened its dermatology portfolio, making it a stronger competitor to Biofrontera in the skin care and treatment market.
Novartis
NVS
Mkt Cap237.61B
Novartis International AG has a significant presence in the dermatology market with products that treat a range of skin conditions, competing with Biofrontera's therapeutic offerings.

About

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Show more...
CEO
Dr. Hermann Luebbert Ph.D.
Employees
92
Country
US
ISIN
US09077D2099

Listings

XNAS
US
BFRI
XNAS
US
BFRIW
XETRA
DE
B8FK.XETRA
F
DE
B8FK.F

0 Comments

Share your thoughts

FAQ

What is Biofrontera stock price today?▼
The current price of BFRI is $0.92 USD — it has increased by +13.83% in the past 24 hours. Watch Biofrontera stock price performance more closely on the chart.
What is Biofrontera stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Biofrontera stocks are traded under the ticker BFRI.
Is Biofrontera stock price growing?▼
BFRI stock has risen by +13.72% compared to the previous week, the month change is a -0.35% fall, over the last year Biofrontera has showed a +14.97% increase.
What is Biofrontera market cap?▼
Today Biofrontera has the market capitalization of 10.73M
When is the next Biofrontera earnings date?▼
Biofrontera is going to release the next earnings report on May 08, 2026.
What were Biofrontera earnings last quarter?▼
BFRI earnings for the last quarter are 0.48 USD per share, whereas the estimation was 0.2 USD resulting in a +146.15% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Biofrontera revenue for the last year?▼
Biofrontera revenue for the last year amounts to 74.64M USD.
What is Biofrontera net income for the last year?▼
BFRI net income for the last year is -35.52M USD.
How many employees does Biofrontera have?▼
As of April 02, 2026, the company has 92 employees.
In which sector is Biofrontera located?▼
Biofrontera operates in the Health Care sector.
When did Biofrontera complete a stock split?▼
The last stock split for Biofrontera was on July 05, 2023 with a ratio of 1:20.
Where is Biofrontera headquartered?▼
Biofrontera is headquartered in Woburn, US.